Encision completes private placement of stock
BOULDER — Encision Inc., a medical device company that has developed technology to prevent stray electrosurgical burns, completed a private placement of 875,000 shares of its common stock.
The private placement to CMED Partners LLLP represents 7.6 percent of the total number of shares. It will raise a total of $350,000 or 40 cents per share, before costs.
“We appreciate the continued confidence that CMED has placed in us,” Greg Trudel, resident and CEO of Encision, said in a prepared statement. “Net proceeds from the sale of the shares will be used for general business purposes and, in particular, for greater sales, marketing, and research and development presence.”
SPONSORED CONTENT
Ways to thank a caregiver
If you have a caregiver or know someone who has been serving as a primary caregiver, March 3rd is the day to reach out and show them how much they are valued!
The securities were offered only to CMED, an accredited investor.
BOULDER — Encision Inc., a medical device company that has developed technology to prevent stray electrosurgical burns, completed a private placement of 875,000 shares of its common stock.
The private placement to CMED Partners LLLP represents 7.6 percent of the total number of shares. It will raise a total of $350,000 or 40 cents per share, before costs.
“We appreciate the continued confidence that CMED has placed in us,” Greg Trudel, resident and CEO of Encision, said in a prepared statement. “Net proceeds from the sale of the shares will be used for general business…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!